国家自然科学基金资助项目(30070267),中国博士后科学基金(2001),辽宁省重点科技攻关课题项目(2001226005).
This work was supported by grants from The Natural Science Foundation of China(30070267), Science Foundation for Postdoctors of China(2001), Science and Technology Foundation of Liaoning Province(2001226005).
为了获得人N-甲基-D-天冬氨酸受体(NR)主亚基(NR1)M3-M4环B细胞表位,以人NR1分子M3-M4环单克隆抗体MAB363淘筛噬菌体展示随机12肽库,对筛选克隆进行特异性ELISA检测和竞争结合实验分析.从30个克隆中得到一个阳性克隆序列“VHTNPSTWQPIL”(克隆1),原核表达的NR1 M3-M4环可以与克隆1竞争结合MAB363.固相合成5个表位探针短肽,发现其中只有R(22)LRNPSKD可以与M3-M4环竞争结合抗体,将NPS三个氨基酸残基逐一敲除,缺失N或NP的合成肽和M3-M4环竞争抗体的能力减弱,缺失NPS的合成肽完全没有竞争能力,证明MAB363的表位为NPS,S可能是关键性残基.上述结论为免疫干预防治兴奋毒性脑损害策略的实施提供了一个重要线索和依据.
To determine the B cell epitope of a monoclonal antibody against the M3-M4 loop of NMDAR1, a random phage displayed dodecapeptide library was screened with the monoclonal antibody MAB363 against the M3-M4 loop of NMDAR1. After four rounds of biopanning,the peptide sequences of positive phage clones were determined and analyzed by DNA sequencing,ELISA and competitive inhibition assay. A positive clone was found (clone1: VHTNPSTWQPIL). The binding between clone1 and MAB363 were competitively inhibited by the recombined M3-M4 loop expressed by E.coli DH5α;The binding between M3M4 and MAB363 could be competitively inhibited by one of solid-synthesized epitope peptides: RLRNPSKD. There were identical sequences among them: NPS. Deleted with NPS, the peptide could not inhibit the binding of MAB363 to M3-M4. These results demonstrate that NPS in M3-M4 loop is the B cell epitope recognized by MAB363,which may be important for developing a practical immunization strategy against excitotoxic brain injury.
康晓楠,孙长凯,范明,薛沿宁,邵宁生,赵杰,韩大跃,施广霞.噬菌体肽库中筛选NMDA受体抗原表位[J].生物化学与生物物理进展,2003,30(4):599-604
复制生物化学与生物物理进展 ® 2025 版权所有 ICP:京ICP备05023138号-1 京公网安备 11010502031771号